BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Simcyp Limited 

Blades Enterprise Centre
John Street
Sheffield    S2 4SU  United Kingdom
Phone: 44-0-114-292-2322 Fax: 44-0-114-292-2333


SEARCH JOBS
Simcyp Limited provides a platform for modelling and simulating in vivo drug absorption, distribution, metabolism and excretion (ADME) using routinely generated in vitro data. The Simcyp Simulator is the industry’s most sophisticated platform for the prediction of drug-drug interactions and pharmacokinetic outcomes in clinical populations. Simcyp’s clients form a Consortium which guides scientific R&D at the company. Simcyp also works closely with drug regulatory agencies and is supported by a scientific advisory board of world-renowned experts.

The Simcyp Simulator is updated annually in consultation the Consortium, which includes nine of the top ten pharmaceutical companies in the world. This ensures the platform meets the needs of the industry. Simcyp’s products and services enable Consortium members to take full advantage of pre-clinical data to identify and manage the limitations of candidate compounds and assess the impact of covariates prior to conducting studies in humans. This helps focus drug development resources and prioritise the right study, at the right time. As a result, unnecessary drug exposure to human volunteers and animals can be minimised.

Simcyp simulations can also help identify pivotal pre-clinical data requirements, which has proved valuable in redefining and optimising early drug development processes and procedures. Simcyp’s science team provides consultancy services on a range of ADME and pharmacokinetics/pharmacodynamics (PK-PD) issues. In addition, Simcyp regularly runs interactive workshops on the optimal use and interpretation of in vitro ADME data. Simcyp Limited is a rapidly expanding company and we are continually looking to recruit talented scientists in the areas of modelling and simulation, biostatistics, pharmacokinetics and clinical pharmacology.


 Key Statistics


Email:
Ownership: Private

Web Site: Simcyp Limited
Employees:
Symbol: 
 









 Company News
Simcyp Limited Releases Version 13 of Its Widely Used Simulato 8/28/2013 10:31:19 AM    More...
Simcyp Limited Releases Version 12 of its Simulator, Extending its Lead in the Application of Population-Based Modelling and Simulation 8/1/2012 10:34:30 AM    More...
Simcyp Limited Releases Version 12 of its Simulator, Extending its Lead in the Application of Population-Based Modelling and Simulation 8/1/2012 9:42:34 AM    More...
Certara Corporation Announces Completion of Acquisition of Simcyp Limited 3/14/2012 6:32:03 AM    More...
Simcyp Limited Acquired by Certara Corporation for $32 Million 2/24/2012 6:28:29 AM    More...
Simcyp Limited Develops Virtual Laboratory Mouse for use in Cancer and Toxicology Research 1/18/2012 8:57:22 AM    More...
Simcyp Limited Releases Virtual Chinese Patient Population as China Increases Its Dominance in the World Pharmaceutical Market 1/9/2012 9:26:08 AM    More...
Simcyp Limited Adds Blood-Brain Barrier Models to Its Population-Based Simulator and Expands Its Pharmacodynamic Capabilities 8/5/2011 9:20:40 AM    More...
Simcyp Limited Appoints Dr Iain Gardner as Head of Translational Science in DMPK 6/21/2011 10:40:19 AM    More...
Simcyp Limited Develops Dog Simulator for Virtual Preclinical Absorption Studies 12/20/2010 9:51:59 AM    More...
12

//-->